TRANSLATE

The aml Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the aml Hub cannot guarantee the accuracy of translated content. The aml and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The AML Hub is an independent medical education platform, sponsored by Astellas, Daiichi Sankyo, Johnson & Johnson, Kura Oncology and Syndax, and has been supported through educational grants from Bristol Myers Squibb and the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

ESH 2020

Our live event feature page helps you keep up to date with the latest in acute myeloid leukemia (AML), fresh from congresses worldwide!

The AML Hub is happy to be providing live coverage from the 2nd How to Diagnose and Treat: Acute Leukaemia conference, which will be taking place in a virtual format from June 30–July 2, 2020. Ensure that you stay up to date by following our Twitter and #ESHAL2020. Following the meeting, the AML Hub will be providing articles on key sessions, as well as interviews with leaders in the AML field — be sure to check our website for the most up-to-date content!

Filter by content:

All Congresses